Aurobindo Pharma informs about issuance of letter of confirmations

08 Dec 2023 Evaluate

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR / 2022 / 8 dated January 25, 2022, Aurobindo Pharma has informed that the Company has approved the issuance of ‘Letter of Confirmations’ in lieu of duplicate share certificates, which were reported as lost by the shareholders: Subhas Kumar Patodia (Folio No: APL033412) & Aruna Ch (Folio No: APL027500), further details are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1258.30 17.60 (1.42%)
23-Dec-2024 12:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.00
Dr. Reddys Lab 1347.85
Cipla 1479.80
Lupin 2179.75
Zydus Lifesciences 977.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.